Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.416ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.263ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.135ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.219ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.208ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.125.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.78 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.159ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.5 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.6.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.237ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBNENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBJ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.356ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.462ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.147ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.6 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.5 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.4 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.420ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.39.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.233ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.320ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.635ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.19 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.15 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.113ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used